关注
Ceccato Filippo
Ceccato Filippo
Endocrinology Unit, Department of Medicine DIMED, University-Hospital of Padova
在 unipd.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas
M Losa, F Bogazzi, S Cannavo, F Ceccato, L Curtò, L De Marinis, ...
Journal of Neuro-Oncology 126, 519-525, 2016
1292016
Salivary cortisol and cortisone by LC–MS/MS: validation, reference intervals and diagnostic accuracy in Cushing's syndrome
G Antonelli, F Ceccato, C Artusi, M Marinova, M Plebani
Clinica chimica acta 451, 247-251, 2015
1072015
Combination therapy for Cushing’s disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole?
M Barbot, N Albiger, F Ceccato, M Zilio, AC Frigo, L Denaro, F Mantero, ...
Pituitary 17, 109-117, 2014
972014
Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency
F Ceccato, M Barbot, M Zilio, S Ferasin, G Occhi, A Daniele, S Mazzocut, ...
European Journal of Endocrinology 169 (1), 31-36, 2013
862013
An analysis of different therapeutic options in patients with C ushing's syndrome due to bilateral macronodular adrenal hyperplasia: a single‐centre experience
NM Albiger, F Ceccato, M Zilio, M Barbot, G Occhi, S Rizzati, A Fassina, ...
Clinical endocrinology 82 (6), 808-815, 2015
852015
Diagnosis and complications of Cushing's disease: gender‐related differences
M Zilio, M Barbot, F Ceccato, V Camozzi, F Bilora, A Casonato, AC Frigo, ...
Clinical endocrinology 80 (3), 403-410, 2014
792014
Screening tests for Cushing's syndrome: urinary free cortisol role measured by LC-MS/MS
F Ceccato, M Barbot, M Zilio, AC Frigo, N Albiger, V Camozzi, G Antonelli, ...
The Journal of Clinical Endocrinology & Metabolism 100 (10), 3856-3861, 2015
772015
Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study
T Deutschbein, G Reimondo, G Di Dalmazi, I Bancos, J Patrova, ...
The Lancet Diabetes & Endocrinology 10 (7), 499-508, 2022
762022
Cushing’s syndrome: screening and diagnosis
F Ceccato, M Boscaro
High Blood Pressure & Cardiovascular Prevention 23, 209-215, 2016
762016
The pathophysiology and treatment of hypertension in patients with Cushing's syndrome
M Barbot, F Ceccato, C Scaroni
Frontiers in endocrinology 10, 321, 2019
712019
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical …
NM Albiger, D Regazzo, B Rubin, AM Ferrara, S Rizzati, E Taschin, ...
Endocrine 55, 959-968, 2017
712017
Increased rate of intracranial saccular aneurysms in acromegaly: an MR angiography study and review of the literature
R Manara, P Maffei, V Citton, S Rizzati, G Bommarito, M Ermani, I Albano, ...
The Journal of Clinical Endocrinology & Metabolism 96 (5), 1292-1300, 2011
702011
Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple …
G Occhi, G Trivellin, F Ceccato, P De Lazzari, G Giorgi, S Dematte, ...
European Journal of Endocrinology 163 (3), 369-376, 2010
642010
Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome
M Barbot, L Trementino, M Zilio, F Ceccato, N Albiger, A Daniele, ...
Pituitary 19, 488-495, 2016
632016
Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center
F Ceccato, G Lombardi, R Manara, E Emanuelli, L Denaro, L Milanese, ...
Journal of Neuro-Oncology 122, 189-196, 2015
622015
Diabetes mellitus secondary to Cushing’s disease
M Barbot, F Ceccato, C Scaroni
Frontiers in endocrinology 9, 284, 2018
612018
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations
ML Jaffrain-Rea, S Rotondi, A Turchi, G Occhi, A Barlier, E Peverelli, ...
Endocrine-Related Cancer 20 (5), 753-766, 2013
612013
The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: mutational hot-spot or founder effect?
G Occhi, ML Jaffrain-Rea, G Trivellin, N Albiger, F Ceccato, E De Menis, ...
Journal of Endocrinological Investigation 33, 800-805, 2010
572010
Perioperative thromboprophylaxis in Cushing’s disease: what we did and what we are doing?
M Barbot, V Daidone, M Zilio, N Albiger, L Mazzai, MT Sartori, AC Frigo, ...
Pituitary 18, 487-493, 2015
552015
Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab
M Caccese, M Barbot, F Ceccato, M Padovan, MP Gardiman, M Fassan, ...
Anti-Cancer Drugs 31 (2), 199-204, 2020
532020
系统目前无法执行此操作,请稍后再试。
文章 1–20